SEARCH

SEARCH BY CITATION

References

  • 1
    Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. HEPATOLOGY 1998; 28: 868880.
  • 2
    De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5: 645663.
  • 3
    Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 22542261.
  • 4
    Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38: 266272.
  • 5
    D'Amico G, Pasta L, Madonia S, Tarantino G, Mancuso A, Malizia G, et al. The incidence of esophageal varices in cirrhosis. Gastroenterology 2001; 120: A2
  • 6
    D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217231.
  • 7
    Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. HEPATOLOGY 1985; 5: 419424.
  • 8
    de Franchis R. Evaluation and follow-up of patients with cirrhosis and oesophageal varices. J Hepatol 2003; 3: 361363.
  • 9
    Perellò A, Escorsell A, Bru C, Gilabert R, Moitinho E, Garcia-Pagàn JC, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. HEPATOLOGY 1999; 30: 13931397.
  • 10
    D'Amico G, De Franchis R, and a cooperative study group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. HEPATOLOGY 2003; 38: 599612.
  • 11
    De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167176.
  • 12
    Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, and the Pratice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. HEPATOLOGY 2007; 46: 922938.
  • 13
    Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, et al. American Society for Gastrointestinal Endoscopy. Complications of upper GI endoscopy. Gastrointest Endosc 2002; 55: 784793.
  • 14
    Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Mel Wilcox C. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999; 94: 32853291.
    Direct Link:
  • 15
    Pilette C, Oberti F, Aub C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases J Hepatol 1999; 31: 867873.
  • 16
    Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999; 94: 32923296.
    Direct Link:
  • 17
    Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002; 34: 8185.
  • 18
    Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? HEPATOLOGY 2001; 33: 333338.
  • 19
    Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52: 12001205.
  • 20
    Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003; 35: 473478.
  • 21
    Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. HEPATOLOGY 2004; 39: 203209.
  • 22
    Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J Gastroenterol Hepatol 2007; 22: 19091915.
  • 23
    Levy C, Zein CO, Gomez J, Soldevila-Pico C, Firpi R, Morelli G, et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 803808.
  • 24
    Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol 2008; 103: 11591167.
    Direct Link:
  • 25
    Perri R, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, et al. A prospective evaluation of computerized tomographic scanning as a screening modality for esophageal varices. HEPATOLOGY 2008; 47: 15871594.
  • 26
    de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. HEPATOLOGY 2008; 47: 15951603.
  • 27
    Eisen GM, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E, et al. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of esophageal varices: a prospective three-center pilot study. Endoscopy 2006; 38: 3135.
  • 28
    Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, et al. Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study. Liver Int 2006; 26: 271278.
  • 29
    D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. HEPATOLOGY 2004; 39: 3034.
  • 30
    Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230235.
  • 31
    Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007; 45: 12901297.
  • 32
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, et al. Insulin resistance, and diabetes, increase fibrosis in the liver of patients with HCV genotype 1 infection. Am Journal Gastroenterol 2008; 103: 11361144.
    Direct Link:
  • 33
    Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840848.
  • 34
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416423.
  • 35
    Camma C, Bruno S, Di Marco V, Di Bona D, Rumi M, Vinci M, et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. HEPATOLOGY 2006; 43: 6471.
  • 36
    Petta S, Cammà C, Di Marco V, Alessi N, Barbaria F, Cabibi D, et al. Retinol-binding protein 4: A new marker of virus-induced steatosis in patients infected with HCV genotype 1. HEPATOLOGY 2008 sub epub.
  • 37
    Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003; 125: 16951704.
  • 38
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412419.
  • 39
    Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001; 48: 8186.
  • 40
    Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography: Fibrotest, APRI and liver biopsy for the assessment of liver fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343350.
  • 41
    The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319: 983989.
  • 42
    SAS Technical Report, SAS/STAS software: changes & enhancement, release 6.07. Cary, NC: SAS Institute Inc, 1992.
  • 43
    Blendis L, Brill S, Oren R. Hepatogenous diabetes: reduced insulin sensitivity and increased awareness. Gastroenterology 2000; 119: 18001802.
  • 44
    Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003; 3: 279288.
  • 45
    Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007; 46: 927934.
  • 46
    Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. HEPATOLOGY 1999; 29: 17431751.
  • 47
    Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M, et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. HEPATOLOGY 2001; 34: 738744.
  • 48
    Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis 2006; 10: 459479.
  • 49
    Spiegel BMR, Targownik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective? HEPATOLOGY 2003; 37: 366377.